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ABSTRACT
Porcine epidemic diarrhoea virus (PEDV) is one of the major pathogens causing acute enteritis, which is
characterised by vomiting and watery diarrhoea and commonly leads to high rates of mortality and
morbidity in suckling piglets. Chitosan has been regarded as a promising natural disinfectant. In this
study, the disinfectant effect and mammalian-cell toxicity of chitosan were evaluated against PEDV
using Vero cells. A 0.01% solution of chitosan was determined to be an effective disinfectant. In
addition, no evidence of toxicity was observed during the cell toxicity test; on the contrary, chitosan
promoted cell proliferation. In conclusion, chitosan is a promising candidate for an effective and safe
disinfectant against PEDV as well as other coronaviruses.
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INTRODUCTION
Porcine epidemic diarrhoea virus (PEDV) is one of the major pathogens causing acute
enteritis, which is characterised by vomiting and watery diarrhoea and commonly leads to
high rates of mortality and morbidity in suckling piglets (Li et al., 2012). In the late 2010s,
new and highly pathogenic strains, designated as G2 strains and having genetic features
distinct from those of the old strains (G1 strains), were reported in China. These new strains
were pathologically more critical than the classic strains, resulting in morbidity rates of 80–
100% and mortality rates of 50–100% in infected suckling piglets (Cima, 2014; Vlasova et al.,
2014). In May 2013, these G2 strains moved from China to the USA and rapidly spread
across the country, massively impacting the swine industry; they affected more than 4,000
farms, accounting for the death of more than 7 million piglets within the year (Cima, 2014;
Vlasova et al., 2014). Subsequently, these strains became pandemic (Lee et al., 2016; Guo
et al., 2019).
Chitosan (formed by the deacetylation of chitin), which is extracted from shellfish such as
crabs and shrimp, is a non-toxic and hydrophilic polysaccharide (Tomihata and Ikada, 1997).
It has been widely used in the medical and bioengineering fields for wound healing,
drug delivery and cell culture, and has a variety of advantageous features, including low
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toxicity, low cost, antimicrobial activity, biodegradability,
and biocompatibility (Khor and Lim, 2003). Among these
advantages, its non-toxic nature and antimicrobial activity
make it a promising substance for use as a less harmful
disinfectant. Thus, we evaluated the disinfectant effect and
safety of chitosan using a human coronavirus surrogate
and Vero cells to identify its potential as a disinfectant for
coronavirus.
MATERIALS AND METHODS
For evaluating the disinfectant effect of chitosan, a 1% chi-
tosan solution was prepared by dissolving chitosan (deace-
tylate level: 95%, molecular weight: 30 kDa) (Nguyen et al.,
2013) in 1% acetic acid solution from NoAH Biotech
(Korea). The PEDV strain DR-13 was cultivated in Vero
cells using the method described by Song et al. (2003). Strain
DR-13 is a PEDV strain attenuated through serial passages
resulting in a 51-nucleotide deletion in the ORF3 gene (Park
et al., 2008), and it is being used for a PED oral vaccine
(DR13 105 TCID50/mL) commercialised in 2003 by Green
Cross Vet. Prod. (South Korea). Virus titration was carried
out using a 96-well microplate with Vero cells. Virus cul-
tures were serially diluted 10-fold with the virus replication
medium containing trypsin. Confluent Vero cells of the
microplate were washed three times with PBS and inocu-
lated at 0.1 mL per well into five wells. Following adsorption
for 1 h at 37 8C, the inocula were removed, and the cells were
washed three times with PBS. Subsequently, 0.1 mL of fresh
virus replication medium containing trypsin was transferred
into each well, and the cells were further incubated for
5 days at 37 8C. Fifty per cent tissue culture infective doses
(TCID50) were expressed as the reciprocal of the highest
virus dilution showing cytopathic effect (CPE) (Kusanagi
et al., 1992). Finally, viral inocula were adjusted to 106.9
TCID50/mL with PBS.
The disinfection test was performed separately under two
different conditions: hard water (0.305 g CaCl2 and 0.139 g
MgCl2$6H2O per 1 L distilled water) and organic water
(5% fetal bovine serum in hard water). The original solution
(1% chitosan) was diluted 100- to 800-fold in both hard and
organic water. Each diluent (1 mL) was mixed with 1 mL of
virus solution (106.9 TCID50/mL) or with 1 mL of non-viral
culture medium for the toxicity control. Hard or organic
water (1 mL) was mixed with 1 mL of the virus solution as
the negative control. The mixtures and the negative controls
(hard or organic water) were incubated at room temperature
for 30 min. Subsequently, viral titrations of each mixture and
the negative controls were performed using the method
Table 1. Antiviral activity of chitosan on porcine epidemic diarrhoea virus
Treatment condition
Experiment (log TCID50/mL)
Effective dilution factorDilution First Second Third Median
Hard water 1:100 0.9 0.9 1.1 0.9 1:150
1:150 1.5 1.5 1.5 1.5
1:200 2.9 3.1 3.1 3.1
1:250 3.3 3.3 3.5 3.3
1:300 3.7 3.9 3.9 3.9
1:400 4.3 4.3 4.3 4.3
1:500 5.5 5.5 5.5 5.5
1:600 5.7 5.9 5.7 5.7
1:800 6.1 6.1 6.1 6.1
Organic water 1:100 2.3 2.1 2.1 2.1 1:100
1:150 2.9 3.1 3.1 3.1
1:200 3.9 3.9 3.9 3.9
1:250 4.3 4.5 4.5 4.5
1:300 4.9 5.1 5.1 5.1
1:400 5.9 5.9 5.9 5.9
1:500 6.1 6.1 6.1 6.1
1:600 6.3 6.3 6.3 6.3
1:800 6.5 6.5 6.5 6.5
Negative control – 6.7 6.7 6.9 6.7 –
Toxicity control 1:100 NCa NC NC – –
1:150 NC NC NC –
1:200 NC NC NC –
1:250 NC NC NC –
1:300 NC NC NC –
1:400 NC NC NC –
1:500 NC NC NC –
1:600 NC NC NC –
1:800 NC NC NC –
a
NC: No cytopathic effect (NC < 0.5).
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described above. Each sample was tested in three replicates.
A maximum dilution factor, in which the virus titre was
reduced by at least 4 log10, was determined to be an effective
dilution factor (Jimenez and Chiang, 2006; de Oliveira et al.,
2011). Additionally, indirect immunofluorescence assays
(IFA) were performed to more precisely detect the presence
of the virus. Before inoculation of the mixture, all procedures
were performed in the same manner as described above. IFA
was carried out using the PEDV IFA kit (MEDIAN Di-
agnostics, South Korea) 24 h after inoculation.
For the safety test, the 1% chitosan solution was diluted
100- to 800-fold in hard water. Hard water without chitosan
was used for the negative controls. A 0.5-mL aliquot of each
diluent and the negative control was inoculated into 1.2 3
104 cells/well seeded in a 24-well plate in which Vero cells
were grown in a monolayer. Each sample was tested in three
replicates. Cell morphology was observed after 24 h.
To investigate the effect of chitosan on cell activity, a cell
culture medium containing chitosan (1% chitosan, 1% acetic
acid, 5% fetal bovine serum, penicillin 100 units/mL, strep-
tomycin 100 mg/mL, and amphotericin B 0.25 g/mL in
DMEM) was prepared. The medium was diluted 2- to 800-
fold with the same solution without chitosan, which was also
used for the negative control. Cell counting was performed
using Countess Cell Counting kits with protocol (Invi-
trogen, USA) at 24, 48, 72, and 96 h after inoculation. Each
sample was tested in duplicate. The cell counting data were
analysed with Tukey’s test using SPSS statistics 20 (IBM
Corp., USA).
RESULTS AND DISCUSSION
In the test of disinfectant effect, some dilutions of chitosan
were highly efficacious at reducing the viral titre. The
effective dilutions under hard and organic water conditions
were 150-fold (0.0067% chitosan) and 100-fold (0.01% chi-
tosan), respectively (Table 1).
The disinfectant effect of chitosan may be affected by
the presence of organic compounds, such as insoluble acid
polysaccharides, in the medium, as chitosan binds to these
substances (Chirkov, 2002), which possibly led to the
Fig. 1. Indirect immunofluorescence assay (IFA) of the disinfectant effect of chitosan. Under hard water conditions, no fluorescence was
observed for the 1-fold (1% chitosan) and 50-fold (0.02% chitosan) dilutions. Under organic water conditions, there was no evidence of
fluorescence in the 1-fold dilution
Fig. 2. Effect of chitosan on the proliferation of cultured Vero cells. Overall, chitosan promoted cell proliferation at all dilutions tested in this
study, and the 50-fold dilution (0.02% chitosan) showed the greatest effect. Letters a, b, c and d indicate chitosan dilution factors showing
significant differences (P < 0.05) compared to the negative control (culture medium without chitosan). Different letters mean that there was
a significant difference (P < 0.05) between two groups
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Fig. 3. Effect of chitosan on the proliferation of Vero cells in culture. No abnormal-appearing cells were observed for any of the chitosan
dilutions during the experiment
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differences observed between the two conditions in this
study. Previous studies have found that chitosan has anti-
viral activity on some phages as well as plant and animal
viruses (Chirkov, 2002; Davis et al., 2012; Zheng et al., 2016).
This activity is known to result from several mechanisms,
including the neutralisation of virus infectivity by changing
its membrane structure or integrity (Kochkina et al., 2000),
blocking viral replication (Kochkina and Chirkov, 2000) and
enhancing host immunity (Zheng et al., 2016). In this study,
the cells were exposed to chitosan for only 1 h during virus
adsorption, thus there was less possibility of chitosan
affecting viral replication. It was also difficult to assess the
immunological effect of chitosan because the test was per-
formed on Vero cells, which are not immune cells in vitro.
Therefore, we believe that the disinfectant effect of chitosan
in this study was derived from its virus-neutralising effect.
The disinfectant effect of chitosan was strongly sup-
ported by the results of the IFA assays (Fig. 1). Under hard
water conditions, no fluorescence was seen for the 1-fold
(1% chitosan) and 50-fold (0.02% chitosan) dilutions. Under
organic water conditions, no fluorescence was found for the
1-fold dilution. Therefore, this new disinfectant completely
eliminated the virus at these degrees of dilution. Overall, the
undiluted solution (1% chitosan) was the most effective.
Nevertheless, considering both efficacy and economic as-
pects, a 0.01% chitosan solution is a reasonable concentra-
tion for commercial products.
In the safety test, no abnormal cell features were
observed. It is noteworthy that all the chitosan dilutions
enhanced cell proliferation (Figs 2 and 3), and the 50-fold
dilution (0.02% chitosan) resulted in the greatest effect
(Fig. 2).
As a result, chitosan is expected to provide significant
benefits to researchers using this cell line. However, chitosan
is known to positively or negatively affect cell proliferation,
depending on its concentration and molecular and
biochemical features. According to Howling et al. (2001),
chitosan enhanced the proliferation of human dermal fibro-
blasts but inhibited that of immortalised human keratino-
cytes. Thus, further studies on other cell lines are required.
Although it is often thought that disinfectants have
broad-spectrum efficacy, certain substances can be effective
or ineffective against specific pathogens, thus a specific
evaluation is necessary (McDonnell and Russell, 1999). This
study is the first to confirm the disinfectant effect of chitosan
on PEDV. Coronaviruses infect a wide range of host species,
including reptiles, birds, and mammals, and can cause res-
piratory or intestinal disease in most hosts. Moreover, the
recently emerged coronaviruses causing Severe Acute Res-
piratory Syndrome (SARS), Middle East Respiratory Syn-
drome (MERS), and SARS-2, which originated from bats,
pose a serious threat to human health (Li et al., 2020).
Generally, it has been known that various types of corona-
virus resemble each other in morphology and chemical
structure (Tyrrell et al., 1996). Thus, it is also expected that
chitosan is highly likely to exert a disinfectant effect on other
coronavirus types including human coronaviruses when
considering its virus neutralisation mechanism. However,
further investigations on other coronaviruses are required to
confirm our hypothesis.
Chitosan has been widely used as a popular biopolymer
ingredient in various industries due to its low cost and ease
of production (Khor and Lim, 2003; Jiang et al., 2014). Thus,
chitosan is considered to be suitable for use as a commercial
disinfectant. Moreover, there is an increasing need for less
harmful disinfectants against coronavirus as Coronavirus
Disease 2019 (COVID-19) has caused a global outbreak.
So far, various chemical disinfectants have been commonly
used for disinfection in human beings as well as companion
animals and livestock, but the toxicity of these chemical
disinfectants in mammals may cause problems (Chang et al.,
2020). In fact, recent data collected by the Centers for
Disease Control and Prevention (CDC) investigators high-
light this risk by showing a 36% increase in poisoning ac-
cidents in the USA from 2019 to 2020 following the COVID-
19 outbreak (Chang et al., 2020). The non-toxicity of chi-
tosan has been widely accepted (Khor and Lim, 2003; Jiang
et al., 2014), and this feature was also confirmed in this
study.
Chitosan appears to be a promising non-toxic and
economical ingredient for disinfectants to be used for pre-
venting coronavirus transmission. This study focused on the
effectiveness of chitosan under liquid conditions; however,
in many situations disinfectants are also used on hard sur-
faces, thus further studies are required to validate the effi-
cacy of chitosan in such situations.
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